Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
It is generally thought that many drug molecules are transported across biological membranes via passive diffusion at a rate related to their lipophilicity. However, the types of biophysical forces involved in the interaction of drugs with lipid membranes are no different from those involved in their interaction with proteins, and so arguments based on lipophilicity could also be applied to drug uptake by membrane transporters or carriers. In this article, we discuss the evidence supporting the idea that rather than being an exception, carrier-mediated and active uptake of drugs may be more common than is usually assumed - including a summary of specific cases in which drugs are known to be taken up into cells via defined carriers - and consider the implications for drug discovery and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that despite a widespread assumption that lipophilicity or log P is sufficient to account for drug distribution this is not in fact the case, as there are hundreds of natural transporters that drugs can use (e.g. [18,1714]).”
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
Citations
Cites
Items 201–265 of 265
Transporter-mediated Drug Interactions
Tsuji, A. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.253 · Cited by 94
Yeast-based functional genomics and proteomics technologies: the first 15 years and beyond
Suter, B., Auerbach, D., & Stagljar, I. (2006) · BioTechniques · doi:10.2144/000112151 · Cited by 93
Quality, not Quantity: The Role of Natural Products and Chemical Proteomics in Modern Drug Discovery
Piggott, A. M. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328409 · Cited by 92
Transporters and Drug Discovery: Why, When, and How
Kim, R. B. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050084o · Cited by 89
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics
Khamdang, S., Takeda, M., Babu, E., Noshiro, R., Onozato, M. L., Tojo, A., Enomoto, A., Huang, X.-L., Narikawa, S., Anzai, N., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01381-5 · Cited by 88
Genetic and Genomic Approaches to Identify and Study the Targets of Bioactive Small Molecules
Zheng, X., Chan, T., & Zhou, H. H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.011 · Cited by 86
Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Lin, J. H. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832578 · Cited by 85
Sala‐Rabanal, M., Loo, D. D. F., Hirayama, B. A., Turk, E., & Wright, E. M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.107904 · Cited by 84
A genomic view of yeast membrane transporters
Belle, D. V., & André, B. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00226-x · Cited by 84
Xia, L., Engel, K., Zhou, M., & Wang, J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00302.2006 · Cited by 81
On the mechanism of human intestinal absorption
Abraham, M. H., Zhao, Y. H., Le, J., Hersey, A., Luscombe, C. N., Reynolds, D. P., Beck, G., Sherborne, B. S., & Cooper, I. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01384-3 · Cited by 80
INTERACTIONS OF AMOXICILLIN AND CEFACLOR WITH HUMAN RENAL ORGANIC ANION AND PEPTIDE TRANSPORTERS
Li, M., Anderson, G. D., Phillips, B., Kong, W., Shen, D. D., & Wang, J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006791 · Cited by 77
Cihlář, T., & Ho, E. S. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4633 · Cited by 77
Dudley, A. J., Bleasby, K., & Brown, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703518 · Cited by 75
Brereton, R. G., Carvalho, A. R., Wasim, M., Yun Xu, A., Zhu, L., & Zomer, S. (2004) · Journal of Chemometrics · doi:10.1002/cem.866 · Cited by 74
A human protein atlas based on antibody proteomics.
Persson, A. B., Hober, S., & Uhlén, M. (2006) · PubMed · Cited by 70
Pang, K. S., Wang, P. J., Chung, A. Y., & Wolkoff, A. W. (1998) · Hepatology · doi:10.1002/hep.510280524 · Cited by 69
Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide
Ishizuka, H., Konno, K., Naganuma, H., Nishimura, K., Kouzuki, H., Suzuki, H., Stieger, B., Meier, P. J., & Sugiyama, Y. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37760-2 · Cited by 67
Systems-ADME/Tox: Resources and network approaches
Ekins, S. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.05.005 · Cited by 66
K., R. (1953) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195304000-00017 · Cited by 65
McDonald, M. D., Wood, C. M., Wang, Y., & Walsh, P. J. (2000) · Journal of Experimental Biology · doi:10.1242/jeb.203.6.1027 · Cited by 62
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Furlanetto, S., & Mura, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.004 · Cited by 62
Tsuda, M., Terada, T., Irie, M., Katsura, T., Niida, A., Tomita, K., Fujii, N., & Inui, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102830 · Cited by 61
Delivery of drugs and macromolecules to mitochondria☆
Mukhopadhyay, A., & Weiner, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.004 · Cited by 61
Pardridge, W. M. (2003) · PubMed · Cited by 61
Sai, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.91 · Cited by 60
Comparison of passive drug transport through Caco-2 cells and artificial membranes
Camenisch, G., Folkers, G., & Waterbeemd, H. V. D. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04796-5 · Cited by 60
Ozawa, N., Shimizu, T., Morita, R., Yokono, Y., Ochiai, T., Munesada, K., Ōhashi, A., Aida, Y., Hama, Y., Taki, K., et al. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048207.11160.d0 · Cited by 59
Kobayashi, Y., Sakai, R., Ohshiro, N., Ohbayashi, M., Kohyama, N., & Yamamoto, T. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003301 · Cited by 57
Calcagno, A. M., Ludwig, J. A., Fostel, J. M., Gottesman, M. M., & Ambudkar, S. V. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050090k · Cited by 56
Kim, R. W. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.01.004 · Cited by 55
Barts, P. W. J. A., Hoeberichts, J. A., Klaassen, A. B., & Borst-Pauwels, G. W. F. H. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90156-x · Cited by 53
Yan, Q., & Sadée, W. (2000) · AAPS PharmSci · doi:10.1208/ps020320 · Cited by 52
Kell, D. B. (2007) · IUBMB Life · doi:10.1080/15216540701694252 · Cited by 52
Self-citationPlanar Lipid Bilayers (BLMs) and Their Applications
(2003) · Membrane science and technology/Membrane science and technology series · doi:10.1016/s0927-5193(03)x8024-9 · Cited by 49
Planar lipid bilayers (BLMs) and their appilcations
Tien, H. T., & Ottova-Leitmannova, A. (2003) · Elsevier eBooks · Cited by 46
COMPARISON OF DRUG EFFLUX TRANSPORT KINETICS IN VARIOUS BLOOD-BRAIN BARRIER MODELS
Bachmeier, C. J., Trickler, W. J., & Miller, D. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006999 · Cited by 46
Transport of cimetidine by flounder and human renal organic anion transporter 1
Burckhardt, B. C., Brai, S., Wallis, S., Krick, W., Wolff, N. A., & Burckhardt, G. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00290.2002 · Cited by 45
Cutler, L., Howes, C., Deeks, N. J., Buck, T., & Jeffrey, P. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20658 · Cited by 45
Mechanisms of Cefadroxil Uptake in the Choroid Plexus: Studies in Wild-Type and PEPT2 Knockout Mice
Ocheltree, S. M., Shen, H., Hu, Y., Xiang, J., Keep, R. F., & Smith, D. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060400 · Cited by 45
Computational approaches for modeling human intestinal absorption and permeability
Subramanian, G., & Kitchen, D. B. (2006) · Journal of Molecular Modeling · doi:10.1007/s00894-005-0065-z · Cited by 44
Devlin, J. P. (1997) · CRC Press eBooks · doi:10.1201/9781482269802 · Cited by 44
Histamine, theophylline and tryptamine transport through lipid bilayer membranes
Gutknecht, J., & Walter, A. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90401-6 · Cited by 43
Allen, D. D., & Geldenhuys, W. J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.004 · Cited by 40
The transport of organic cations in the small intestine: Current knowledge and emerging concepts
Kim, M. K., & Shim, C. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02969273 · Cited by 38
Tissue selective drug delivery utilizing carrier-mediated transport systems
Tsuji, A. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00043-7 · Cited by 35
A chemical genomics approach to understanding drug action
Giaever, G. N. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00225-6 · Cited by 34
Marsden, R. L., Ranea, J. A. G., Sillero, A., Redfern, O., Yeats, C., Maibaum, M., Lee, D., Addou, S., Reeves, G. A., Dallman, T. J., et al. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1801 · Cited by 34
Thallous ion is accumulated by potassium transport systems in Escherichia coli
Damper, P. D., Epstein, W., Rosen, B. P., & Sorensen, E. N. (1979) · Biochemistry · doi:10.1021/bi00586a018 · Cited by 32
Target Identification Strategies in Chemical Genetics
Tochtrop, G. P. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328391 · Cited by 32
Permeability through DOPC/dodecane membranes: measurement and LFER modelling
Huque, F. T. T., Box, K. J., Platts, J. A., & Comer, J. E. A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.07.009 · Cited by 28
Li, Y., Tanno, M., Itoh, T., & Yamada, H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00299-9 · Cited by 26
Glutarimide: a carrier transporting drug through cell membranes
Michalska, D., Morzyk-Ociepa, B., Bieńko, D. C., & Wojciechowski, W. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0879 · Cited by 21
Glycerol Uptake in HCT-15 Human Colon Cancer Cell Line by Na+-Dependent Carrier-Mediated Transport
Fujimoto, N., Inoue, K., Hayashi, Y., & Yuasa, H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.150 · Cited by 19
Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.
Catnach, S. M., Fairclough, P. D., & Hammond, S. M. (1994) · Gut · doi:10.1136/gut.35.4.441 · Cited by 18 · cited 1×
“The case of peptide transporters is particularly clea”
BackgroundIn vitro prediction of brain penetration – a case for free thinking?
Summerfield, S. G., & Jeffrey, P. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.6.595 · Cited by 18
Vicens, M., Medarde, M., Macı́as, R. I. R., Larena, M. G., Villafaina, A., Serrano, M. A., & Marı́n, J. J. G. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.027 · Cited by 17
9-Aminoacridine, a fluorescent probe of the thiamine carrier in yeast cells
Theuvenet, A. P. R., van de Wijngaard, W. M. H., & Borst-Pauwels, G. W. F. H. (1983) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(83)90341-3 · Cited by 13
Knocking Down Transport: Applications of RNA Interference in The Study of Drug Transport Proteins
Tian, X., Zhang, P., Zamek‐Gliszczynski, M. J., & Brouwer, K. L. R. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500364098 · Cited by 12
Conformational and spacial preferences for substrates of PepT1
Bailey, P. D., Boyd, C. A. R., Collier, I. D., George, J. G., Kellett, G. L., Meredith, D., Morgan, K. M., Pettecrew, R., Price, R. A., & Pritchard, R. G. (2005) · Chemical Communications · doi:10.1039/b510697d · Cited by 10
Mitsuoka, K., Kato, Y., Kubo, Y., & Tsuji, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010405 · Cited by 10
Ion transport in lipid bilayer membranes through aqueous pores
Bordi, F. (1999) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(99)00277-0 · Cited by 9
Transporters involved in apical and basolateral uptake of ceftibuten into Caco‐2 cells
Menon, R. M., & Barr, W. H. (2002) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.324 · Cited by 9
Yoshioka, K., Nishimura, H., & Hasegawa, T. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90182-8 · Cited by 7
Planar lipid bilayers (BLMs) and their applications
Tien, H. T., & Ottova-Leitmannova, A. (2003) · Cited by 3
Research works printed but not linked: 1
- Jain, M. K. The Bimolecular Lipid Membrane. (Van Nostrand Reinhold, New York, 1972).
Cited by
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
The impact of natural products upon modern drug discovery
Ganesan, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.016 · Cited by 646
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
“Consequently, it would be interesting to discuss whether carrier-mediated transport is the ubiquitous and dominant mechanism of biological membrane permeation for most drugs in most organ”
BackgroundUnderstanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Metadata
- Authors
- Dobson, P. D., & Kell, D. B.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Kell, Douglas B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-03
- Volume
- 7
- Issue
- 3
- Pages
- 205-220
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2157619122
- Cited by
- 475
- References
- 265
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 19 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 20 · 2018: 17 · 2017: 28 · 2016: 36 · 2015: 43 · 2014: 42 · 2013: 29 · 2012: 36
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Royal Society
- Wolfson Foundation
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council (747/1, BB/D007)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- passive diffusion, lipophilicity, membrane transporters, drug discovery, drug development
- MeSH terms
- Animals, Biological Transport, Cell Membrane, Cell Membrane Permeability, Pharmaceutical Preparations, Humans, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.